Paris Saclay Cancer Cluster (PSCC)
Created in 2022
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
7,109Activities
Entity types
Location
94800 Villejuif, France
Villejuif
France
Employees
Scale: 2-10
Estimated: 20
Engaged corporates
36
14 29Added in Motherbase
1 year, 8 months ago
deeptech Value proposition
Bringing together the actors of oncology innovation to develop solutions in France for the patients.
As the first winner of the France 2030 NextGenerationEU program, the Paris Saclay Cancer Cluster (PSCC) is changing the pace of innovation in oncology to make it more predictive, precise, and efficient.
🚀 To accelerate this transformation, the French oncocluster is offering access to the best expertise, tools, and services for promising European researchers and developers, including mentors, networks, funding, data, samples, technologies, infrastructures, and laboratories.
🌟 This unique patient-driven ecosystem in the heart of Greater Paris, close to major French research, clinical, and innovation centers, is the largest in Europe, with nearly 80 members and 9 nationalities.
💡 Created in February 2022 at the initiative of the Paris-Saclay University, the Polytechnic Institute of Paris, Inserm, the Gustave Roussy Institute and Sanofi, the PSCC is a continuum of excellence, bringing together research organizations, universities, hospitals, start-ups, scale-ups, industrialists, capital investors, patient associations, government, local authorities, and stakeholders.
Chaired by Professors Eric Vivier and Solange Peters, the association and its Strategic Advisory Board reflect the cluster's twofold ambition: to change the destiny of millions of patients and to position France and Europe at the forefront of the world's leading pharmaceutical industry.
oncologie, Cancer, Innovation, and OncoclusterOriginal language
Bringing together the actors of oncology innovation to develop solutions in France for the patients.
As the first winner of the France 2030 NextGenerationEU program, the Paris Saclay Cancer Cluster (PSCC) is changing the pace of innovation in oncology to make it more predictive, precise, and efficient.
🚀 To accelerate this transformation, the French oncocluster is offering access to the best expertise, tools, and services for promising European researchers and developers, including mentors, networks, funding, data, samples, technologies, infrastructures, and laboratories.
🌟 This unique patient-driven ecosystem in the heart of Greater Paris, close to major French research, clinical, and innovation centers, is the largest in Europe, with nearly 80 members and 9 nationalities.
💡 Created in February 2022 at the initiative of the Paris-Saclay University, the Polytechnic Institute of Paris, Inserm, the Gustave Roussy Institute and Sanofi, the PSCC is a continuum of excellence, bringing together research organizations, universities, hospitals, start-ups, scale-ups, industrialists, capital investors, patient associations, government, local authorities, and stakeholders.
Chaired by Professors Eric Vivier and Solange Peters, the association and its Strategic Advisory Board reflect the cluster's twofold ambition: to change the destiny of millions of patients and to position France and Europe at the forefront of the world's leading pharmaceutical industry.
Biocluster | Paris-saclay Cancer Cluster
Le Paris Saclay Cancer Cluster est avant tout un lieu de convergence des acteurs pluridisciplinaires travaillant tous pour la lutte contre le cancer.
https://www.parissaclaycancercluster.org/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Astellas Pharma Pharmaceutical | Astellas Pharma Pharmaceutical | Other 2 Oct 2024 | | |
 Sofinnova Partners Financial Services | Sofinnova Partners Financial Services | Other 1 Oct 2024 | | |
 Technofounders Research, Research Services | Technofounders Research, Research Services | Other 1 Oct 2024 | | |
 Kurma Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Kurma Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 1 Oct 2024 | | |
 Elaia Startup accelerator & VC, Venture Capital and Private Equity Principals | Elaia Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 1 Oct 2024 | | |
 Linksium Venture Capital and Private Equity Principals | Linksium Venture Capital and Private Equity Principals | Other 24 Sep 2024 | | |
 Seventure Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Seventure Partners Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 22 Aug 2024 | | |
 | Edmond de Rothschild | Other 22 Jun 2024 | | |
 Business France National and local authorities, Government Administration | Business France National and local authorities, Government Administration | Other 21 Jun 2024 | | |
 Ipsen Pharmaceutical, Pharmaceutical Manufacturing | Ipsen Pharmaceutical, Pharmaceutical Manufacturing | Other 12 Nov 2024 | | |